TherapeuticsMD News - TXMD

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
TherapeuticsMD Inc TXMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.21 -16.28% 1.08 1.04 1.22 1.19 1.29 00:00:03
more quote information »

Recent News

Date Time Source Heading
3/26/202016:08EDGARCurrent Report Filing (8-k)
3/26/202016:05BWTherapeuticsMD Provides COVID-19-Related Business Update
3/24/202007:54EDGARCurrent Report Filing (8-k)
3/24/202007:45BWTherapeuticsMD Strengthens Board with Appointment of..
3/16/202006:00BWTherapeuticsMD Provides Business Update on COVID-19 Pandemic
3/03/202007:02EDGARCurrent Report Filing (8-k)
2/27/202007:00BWTherapeuticsMD Announces Participation at the Cowen 40th..
2/24/202016:57EDGARPost-effective Amendment to Registration Statement (pos Am)
2/24/202016:19EDGARAnnual Report (10-k)
2/24/202016:10EDGARPost-effective Amendment to an Automatic Shelf Registration..
2/20/202006:58EDGARCurrent Report Filing (8-k)
2/20/202006:57BWTherapeuticsMD Announces Fourth Quarter and Full-Year 2019..
2/14/202013:42EDGARAmended Statement of Ownership (sc 13g/a)
2/13/202006:30BWTherapeuticsMD and Afaxys Enter Into Agreement to Expand..
2/12/202011:16EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202006:30BWTherapeuticsMD to Report Fourth Quarter 2019 Results on..
2/07/202011:33EDGARAmended Statement of Ownership (sc 13g/a)
2/06/202009:14EDGARAmended Statement of Ownership (sc 13g/a)
2/05/202018:07EDGARStatement of Changes in Beneficial Ownership (4)
2/03/202006:30BWTherapeuticsMD Announces Submission of New Drug Application..
1/21/202009:29EDGARAmended Statement of Ownership (sc 13g/a)
1/07/202006:30BWTherapeuticsMD, an Innovative Women’s Healthcare Company, &..
1/06/202006:55BWTherapeuticsMD Announces Participation at the JP Morgan..
12/30/201907:03EDGARCurrent Report Filing (8-k)
12/30/201906:55BWTherapeuticsMD Announces Amendment to Term Loan Financing..
12/18/201917:28EDGARCurrent Report Filing (8-k)
12/10/201914:55EDGARAmended Statement of Ownership (sc 13g/a)
11/26/201907:30BWKnight and TherapeuticsMD Announce Filing of New Drug..
11/19/201906:48EDGARCurrent Report Filing (8-k)
11/12/201907:00BWTherapeuticsMD Announces Participation at the Stifel 2019..
11/08/201916:19EDGARQuarterly Report (10-q)
11/06/201916:11EDGARCurrent Report Filing (8-k)
11/06/201916:05BWTherapeuticsMD Announces Third Quarter 2019 Financial..
11/01/201916:05BWTherapeuticsMD to Report Third Quarter 2019 Results on..
10/30/201917:05BWKnight and TherapeuticsMD Announce Filing of New Drug..
10/29/201917:18EDGARStatement of Changes in Beneficial Ownership (4)
10/29/201917:17EDGARStatement of Changes in Beneficial Ownership (4)
10/29/201917:16EDGARStatement of Changes in Beneficial Ownership (4)
10/29/201916:05BWTherapeuticsMD Announces Closing of Its Underwritten Public..
10/29/201908:53EDGARCurrent Report Filing (8-k)
10/25/201916:48EDGARProspectus Filed Pursuant to Rule 424(b)(2) (424b2)
10/24/201919:46BWTherapeuticsMD Announces Pricing of Its Underwritten Public..
10/24/201906:03EDGARFree Writing Prospectus - Filing Under Securities Act Rules..
10/23/201917:25EDGARCurrent Report Filing (8-k)
10/23/201917:16EDGARFree Writing Prospectus - Filing Under Securities Act Rules..
10/23/201917:16EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
10/23/201916:45BWTherapeuticsMD Announces Proposed Underwritten Public..
10/23/201916:41BWTherapeuticsMD Announces Estimated Third Quarter 2019..
10/15/201907:03EDGARCurrent Report Filing (8-k)
10/11/201907:00BWTherapeuticsMD Announces Presentations on ANNOVERA™ at the..
See more news about this stock »

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.